Yi M. Qin

Radiation Oncology Key Laboratory Of Sichuan Province
Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Stereotactic body radiation therapy for ultra-central lung malignancies: an updated systematic review and meta-analysis.

Stereotactic body radiation therapy for ultra-central lung malignancies: an updated systematic review and meta-analysis.

Journal: Radiation oncology (London, England)

Published: December 09, 2025

Cost-effectiveness analysis of enfortumab vedotin and pembrolizumab versus chemotherapy for patients with untreated advanced urothelial cancer in the United Kingdom.

Cost-effectiveness analysis of enfortumab vedotin and pembrolizumab versus chemotherapy for patients with untreated advanced urothelial cancer in the United Kingdom.

Journal: BMJ open

Published: December 08, 2025

Nivolumab plus ipilimumab versus lenvatinib or sorafenib for US and Chinese patients with unresectable hepatocellular carcinoma: a cost-effectiveness analysis.

Nivolumab plus ipilimumab versus lenvatinib or sorafenib for US and Chinese patients with unresectable hepatocellular carcinoma: a cost-effectiveness analysis.

Journal: Frontiers in public health

Published: October 18, 2025

Cost-effectiveness of tarlatamab versus chemotherapy for patients with small-cell lung cancer after platinum-based chemotherapy in the United States and China.

Cost-effectiveness of tarlatamab versus chemotherapy for patients with small-cell lung cancer after platinum-based chemotherapy in the United States and China.

Journal: Frontiers in pharmacology

Published: October 07, 2025

The Role of Mitochondria-Associated Endoplasmic Reticulum Membranes in Fibrotic Diseases.

The Role of Mitochondria-Associated Endoplasmic Reticulum Membranes in Fibrotic Diseases.

Journal: Aging and disease

Published: August 23, 2025

A cost-effectiveness analysis of amivantamab plus lazertinib versus osimertinib in the treatment of US and Chinese patients with EGFR-mutated advanced non-small cell lung cancer.

A cost-effectiveness analysis of amivantamab plus lazertinib versus osimertinib in the treatment of US and Chinese patients with EGFR-mutated advanced non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 07, 2025

Relationships between systemic sclerosis and atherosclerosis: screening for mitochondria-related biomarkers.

Relationships between systemic sclerosis and atherosclerosis: screening for mitochondria-related biomarkers.

Journal: Frontiers in genetics

Published: January 23, 2024

Factors Impacting One-year Follow-up Visit Adherence after Bariatric Surgery in West China: A Mixed Methods Study.

Factors Impacting One-year Follow-up Visit Adherence after Bariatric Surgery in West China: A Mixed Methods Study.

Journal: Obesity surgery

Published: January 08, 2024

Cost-effectiveness of atezolizumab versus chemotherapy in patients with non-small-cell lung cancer ineligible for platinum-based doublet chemotherapy.

Cost-effectiveness of atezolizumab versus chemotherapy in patients with non-small-cell lung cancer ineligible for platinum-based doublet chemotherapy.

Journal: Frontiers in public health

Published: December 05, 2023

RARPKB: a knowledge-guide decision support platform for personalized robot-assisted surgery in prostate cancer.

RARPKB: a knowledge-guide decision support platform for personalized robot-assisted surgery in prostate cancer.

Journal: International journal of surgery (London, England)

Published: October 10, 2023

The influence of learning strategies and the environment on Chinese L3 English learners' motivation to learn phonetic symbols: The mediating role of self-efficacy.

The influence of learning strategies and the environment on Chinese L3 English learners' motivation to learn phonetic symbols: The mediating role of self-efficacy.

Journal: PloS one

Published: June 15, 2023

Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi-center study.

Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi-center study.

Journal: Cancer science

Published: September 08, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026